NAVROZE MEHTA, FOUNDER
Navroze Mehta, Founder of Ovation Diagnostics LLC, has over 15 years of experience in developing early stage medical devices. Most recently he was Managing Partner of MDI Partners LLC (www.mdipartners.com) where he used a unique innovation and development framework to bring devices to market. One of those spin outs is ClearSpec LLC (www.clearspecmedical.com). Prior to MDI Partners, he was the Founder and CEO of NovaVision Inc.(www.novavision.com), a venture-backed company providing neurostimulation devices to restore vision in stroke and traumatic brain injury patients. Before that he was President and CEO of Skinstore (www.skinststore.com) a successful B2C Company.
Navroze is a member of Young Presidents Organization (YPO), past chair of the Americas Gateway Chapter, and served as Regional Chair of the Economic Development Network. He is also an active member of the Ashoka Support Network (www.ashoka.org), a leader in the field of social entrepreneurship. Navroze also co-founded Mela Artisans Inc. (www.melaartisans.com) with his daughter Sonali Mehta Rao. Mela Artisans is a novel social for profit enterprise that was formed to create a global marketplace for artisans worldwide with a goal of preserving the livelihood of artisans. Navroze also served on the Board of Directors of Mission Markets Inc., a company that is focused on connecting impact investors to mission-focused organizations. Navroze received an MBA from Syracuse University and a Bachelor of Commerce degree from Sydenham College at the University of Bombay, India.
JOSEPH ZACK, PRESIDENT
Mr. Zack has been a C-level Life Sciences Executive for 20 years, spanning Biopharma to Diagnostics, from start-up to blue chip global companies. He has a strong track record of success and has built commercial organizations from “scratch”, has taken from inception to launch over a dozen products in his career, added to top and bottom line results with successful business development spanning Europe, Asia, Africa, and South America, and has played a significant role in capital formation. Mr. Zack’s particular domain expertise includes infectious disease, oncology, and endocrine diagnostics, regenerative medicine, wound healing, cardiovascular, neurology, and periodontal medicine.
Mr. Zack’s most recent corporate role was as Senior Vice President Diagnostics at Metabolon. Other companies where he had senior leadership roles included OraSure Technologies (Executive VP Sales and Marketing), OraPharma (Senior VP Sales and Marketing), Advanced Tissue Sciences (General Manager), and Ciba-Geigy (now Novartis, Executive Director).
Mr. Zack is the Principal of Zack Consulting Services, which advises early and mid cap domestic and international companies, at the C-level, with business strategy, opportunity assessments, commercialization plans, product development, business development, and capital formation. Mr. Zack has a BA in Biology from Colgate University, and an MBA from St. John’s University.
ROBERT BOHANNON, Ph.D, CONSULTANT, RESEARCH AND DEVELOPMENT
Dr. Robert Bohannon joined Ovation Diagnostics in 2016 as a Scientific Consultant. He is an industry recognized IVD scientist with over thirty years of scientific experience in development of EIA, lateral flow assay and molecular diagnostics. Through his career, he has been involved in the creation and launch of a few hundred diagnostic products including the OraQuick ™ HIV saliva test (FDA cleared), Sure Screen™ drug of abuse test system (FDA cleared), avian influenza (H5N1, FDA cleared) and many others. He also possesses expertise in development of biowarfare diagnostics. Dr. Bohannon contributed to 11 patents.
Dr. Bohannon currently serves as the President of Catalloid Products Inc where he oversees the development of immunoassay related products for the diagnostic industry. Prior to that he was the Head of Product Development at Vigilant Biosciences where he developed a novel immunoassay for oral cancer detection. Dr. Bohannon also oversaw more than 60 projects related to diagnostic tests while serving as the Director of R&D at Agdia. He was also the Vice President of Technology, Research and Development at MedTox Diagnostics, the Chief Scientific Officer at Osborne Scientific Group and Director of Research and Development, Lab Director at Epitope Inc.
Dr. Robert Bohannon has a PhD in Molecular Virology from the Baylor School of Medicine and has contributed to over twenty peer-reviewed scientific publications.